Sources and outcome for methicillin-resistant Staphylococcus aureus bacteraemia

M T Cafferkey1, R Hone, C T Keane

  • 1Department of Clinical Microbiology, Trinity College, St. James's Hospital.

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) sepsis is often fatal, particularly in older patients or those with severe underlying conditions. Prompt identification and management are crucial for improving outcomes in MRSA bacteremia.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Critical Care Medicine

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of hospital-acquired infections.
  • MRSA bloodstream infections (septicemia) are associated with high morbidity and mortality.
  • Understanding risk factors and outcomes is crucial for effective patient management.

Purpose of the Study:

  • To prospectively investigate the clinical characteristics and outcomes of MRSA septicemia.
  • To identify patient demographics and predisposing factors associated with MRSA bacteremia.
  • To determine common sources of infection and mortality rates.

Main Methods:

  • Prospective study of 88 episodes of MRSA septicemia in 82 patients.
  • Data collection included patient demographics, comorbidities, infection sources, and outcomes (transient bacteremia, non-fatal, fatal).
  • Statistical analysis to compare characteristics between different outcome groups.

Main Results:

  • MRSA septicemia had a high mortality rate, with 33 fatal episodes and 4 where it was a major contributor to death.
  • Patients aged over 60 and those with recent surgery or severe underlying disease were more prone to septicemia.
  • Circulation access sites were the most common source, followed by non-surgical wounds like burns.

Conclusions:

  • MRSA septicemia poses a significant threat, especially to elderly and critically ill patients.
  • Early recognition of risk factors and infection sources is vital.
  • Improved strategies are needed to reduce the mortality associated with MRSA bacteremia.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...